Equine Healthcare Market By Product Type (Drug Type, Vaccine Type,Supplements and Additives), By Disease Type (West Nile Virus, Equine Rabies, Potomac Horse Fever, Tetanus, Equine Influenza, Equine Herpes Virus)- Growth, Future Prospects & Competitive Analysis, 2018 - 2026
The global equine healthcare market held US$ 626.2 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 4.0% during the forecast period from 2018 to 2026. Growing trend of horse breeding and horse riding for leisure purpose is the major growth factor of the equine healthcare market. Other factors such as growing incidence of equine infections and development of novel animal safety and health programs will continue to assist the growth of the market. Horse racing for gambling and leisure purpose is highly active in region such as North America, Europe and Asia Pacific which stimulates the demand for equine healthcare products in the region. The companies operating in the market are engaging in research and development of novel products to gain competitive edge in the market.
"Drug Segment to Drive the Global Equine Healthcare Market"
In 2017, drugs segment held the largest share in the global equine healthcare market owing to growing demand for therapeutic drugs for the treatment of various diseases. Horses are highly prone to diseases such as tetanus, equine encephalomyelitis, rabies, equine influenza, West Nile virus among others which needs to be taken care of. The drugs segment is further segmented in to anti-infective, anti-inflammatory and anti-parasitic drugs. Vaccines held the second largest market is projected to grow at a steady rate during the forecast period. Supplements and additives are expected to exhibit fastest growth rate due to high product launch and growing awareness regarding the benefits of supplements among the equine care takers.
Historical & Forecast Period
This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments calculated for the forecast period from 2018 to 2026.
Market is studied in order to understand the current dynamics and future trends in the global equine healthcare market. The study includes market size and forecast for all considered segments presented in the report for the period from 2016 to 2026, along with respective compound annual growth rate (CAGRs) for the forecast period from 2018 to 2026, considering 2017 as the base year. The key players currently engaged in equine healthcare market include Zoetis, Bayer AG, Boehringer Ingelheim (Merial), Vetoquinol S.A., Purina Animal Nutrition LLC, Merck & Co. (Merck Animal Health) among others.
Key questions answered in this report
- How the global equine healthcare market will perform during the forecast period from 2018 to 2026?
- What are the latest trends in the equine healthcare market and valuable opportunities for key players?
- Who are the leading players in the global equine healthcare market?
- Which is the leading/and fastest region in the global equine healthcare market?
- What are drivers and restrains governing the global equine healthcare market?
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global EH Market Portraiture
2.2. Global EH Market, by Product Type, 2017 (US$ Mn)
2.3. Global EH Market, by Disease Type, 2017 (US$ Mn)
2.4. Global EH Market, by Geography, 2017 (US$ Mn)
Chapter 3. Equine Healthcare (EH) Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global EH Market, by Key Players, 2017
Chapter 4. Global Equine Healthcare (EH) Market, by Product Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Drug Type
4.2.1. Anti-Infective
4.2.2. Anti-Inflammatory
4.2.3. Parasiticides
4.2.4. Others
4.3. Vaccine Type
4.3.1. Inactivated
4.3.2. Live Attenuated
4.3.3. Recombinant
4.3.4. Others
4.4. Supplements and Additives
Chapter 5. Global Equine Healthcare (EH) Market, by Disease Type, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. West Nile Virus
5.3. Equine Rabies
5.4. Potomac Horse Fever
5.5. Tetanus
5.6. Equine Influenza
5.7. Equine Herpes Virus
Chapter 6. Global Equine Healthcare (EH) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America EH Market Analysis, 2016 – 2026
6.1.1. North America EH Market, by Product Type, 2016 - 2026 (US$ Mn)
6.1.2. North America EH Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.1.3. North America EH Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. U.S.
6.1.3.2. Canada
6.2. Europe EH Market Analysis, 2016 – 2026
6.2.1. Europe EH Market, by Product Type, 2016 - 2026 (US$ Mn)
6.2.2. Europe EH Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.2.3. Europe EH Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific EH Market Analysis, 2016 – 2026
6.3.1. Asia Pacific EH Market, by Product Type, 2016 - 2026 (US$ Mn)
6.3.2. Asia Pacific EH Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.3.3. Asia Pacific EH Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. Rest of Asia Pacific
6.4. Latin America EH Market Analysis, 2016 – 2026
6.4.1. Latin America EH Market, by Product Type, 2016 - 2026 (US$ Mn)
6.4.2. Latin America EH Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.4.3. Latin America EH Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa EH Market, 2016 – 2026
6.5.1. Middle East & Africa EH Market, by Product Type, 2016 - 2026 (US$ Mn)
6.5.2. Middle East & Africa EH Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.5.3. Middle East & Africa EH Market, by Region, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa
Chapter 7. Company Profiles
7.1. Bayer AG (Bayer Animal Health)
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Boehringer Ingelheim
7.3. Ceva Sante Animale
7.4. Eli Lilly and Company
7.5. Equine Products U.K. Ltd.
7.6. Merck & Co. (Merck Animal Health)
7.7. Purina Animal Nutrition LLC
7.8. Vetoquinol S.A.
7.9. Zoetis
Note: Modification in the list of company profiles or scope of the study can be incorporated on request.
* EH - Equine Healthcare
TABLE 1 Global Equine Healthcare (EH) Market Portraiture
TABLE 2 Global EH Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Drug Type in EH Market, 2016 – 2026 (US$ Mn)
TABLE 4 Global Vaccine Type in EH Market, 2016 – 2026 (US$ Mn)
TABLE 5 Global EH Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 6 Global EH Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 7 North America EH Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 8 North America EH Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 9 North America EH Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10 Europe EH Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 11 Europe EH Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 12 Europe EH Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific EH Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific EH Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific EH Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America EH Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 17 Latin America EH Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America EH Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East & Africa EH Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 20 Middle East & Africa EH Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 21 Middle East & Africa EH Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 22 Bayer AG (Bayer Animal Health): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Ceva Sante Animale: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Equine Products U.K. Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Merck & Co. (Merck Animal Health): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Purina Animal Nutrition LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Vetoquinol S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Zoetis: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
FIG 1. Equine Healthcare (EH) Market: Research Methodology
FIG 2. EH Market Segmentation
FIG 3. Global EH Market, by Product Type, 2017 (US$ Mn)
FIG 4. Global EH Market, by Disease Type, 2017 (US$ Mn)
FIG 5. Global EH Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global EH Market, by Key Players, 2017
FIG 8. Global Anti-Infective Market in Equine Healthcare, 2016-2026 (US$ Mn)
FIG 9. Global Anti-Inflammatory Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 10. Global Parasiticides Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 11. Global Other Drugs Market kin Equine Healthcare, 2016-2026(US$ Mn)
FIG 12. Global Inactivated Vaccines Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 13. Global Live Attenuated Vaccines Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 14. Global Recombinant Vaccines Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 15. Global Other Vaccines Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 16. Global Supplement and Additives Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 17. Global West Nile Virus Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 18. Global Equine Rabies Disease Market in Equine Healthcare , 2016-2026(US$ Mn)
FIG 19. Global Potomac Horse Fever Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 20. Global Tetanus Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 21. Global Equine Influenza Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 22. Global Equine Herpes Virus Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 23. U.S. EH Market, 2016-2026 (US$ Mn)
FIG 24. Canada EH Market, 2016-2026 (US$ Mn)
FIG 25. U.K. EH Market, 2016-2026 (US$ Mn)
FIG 26. Germany EH Market, 2016-2026 (US$ Mn)
FIG 27. Rest of Europe EH Market, 2016-2026 (US$ Mn)
FIG 28. China EH Market, 2016-2026 (US$ Mn)
FIG 29. Japan EH Market, 2016-2026 (US$ Mn)
FIG 30. Rest of Asia Pacific EH Market, 2016-2026 (US$ Mn)
FIG 31. Brazil EH Market, 2016-2026 (US$ Mn)
FIG 32. Mexico EH Market, 2016-2026 (US$ Mn)
FIG 33. Rest of Latin America EH Market, 2016-2026 (US$ Mn)
FIG 34. GCC EH Market, 2016-2026 (US$ Mn)
FIG 35. Rest of Middle East & Africa EH Market, 2016-2026 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)